Vraylar 3 MG capsule 30S
Ended Awarded
- Contract number
- SPE2DB25FYDG3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $31,038
Award facts
- Contract value 100% obligated
- $31,037.56 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Competed under SAP Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $31,037.56 to AmerisourceBergen Drug Corp for the supply of Vraylar 3 mg capsules (30-count units) on July 14, 2025, with completion scheduled for July 15, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and is performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement and holds a significant indefinite delivery contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 through December 2026.
This delivery order is executed under AmerisourceBergen's comprehensive pharmaceutical prime vendor IDC, which enables the company to supply a broad range of brand-name and generic medications, vaccines, and medical supplies to support military and federal healthcare systems globally. Vraylar, a neurological treatment medication, aligns with the company's extensive pharmaceutical portfolio delivered across multiple therapeutic domains to support Defense Health Agency operations and other federal healthcare customers. The competitively awarded contract reflects the contractor's established capability to meet federal medical supply requirements through the DLA's flexible and efficient delivery order mechanism.
Quick answers
Who was awarded contract SPE2DB25FYDG3?
SPE2DB25FYDG3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 14, 2025.
How much is contract SPE2DB25FYDG3 worth?
The government has obligated $31,038 on SPE2DB25FYDG3.
Is contract SPE2DB25FYDG3 an order under another contract?
Yes. SPE2DB25FYDG3 is a delivery order under SPE2DB24D1104, an indefinite delivery contract.
Was contract SPE2DB25FYDG3 competed?
The extent of competition for SPE2DB25FYDG3 was competed under sap.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award